SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040556
Filing Date
2023-08-09
Accepted
2023-08-09 16:08:51
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-20230630.htm   iXBRL 10-Q 2557810
2 EX-10.1 kura-ex10_1.htm EX-10.1 29698
3 EX-10.2 kura-ex10_2.htm EX-10.2 195820
4 EX-31.1 kura-ex31_1.htm EX-31.1 13682
5 EX-32.1 kura-ex32_1.htm EX-32.1 11663
  Complete submission text file 0000950170-23-040556.txt   7686836

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kura-20230630.xsd EX-101.SCH 31227
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kura-20230630_pre.xml EX-101.PRE 193465
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kura-20230630_lab.xml EX-101.LAB 293412
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kura-20230630_cal.xml EX-101.CAL 41733
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kura-20230630_def.xml EX-101.DEF 91969
44 EXTRACTED XBRL INSTANCE DOCUMENT kura-20230630_htm.xml XML 1410695
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 231155183
SIC: 2834 Pharmaceutical Preparations